Setting the scene for Group A Streptococcus vaccine studies: The complete clinical spectrum of severe acute disease is present in Auckland, Aotearoa New Zealand (#117)

5:30 PM

Andrew Fox-Lewis

Poster Session 1

Tracking the relationship between community Strep A infections and Acute Rheumatic Fever in Auckland, New Zealand: 2018-2024 (#103)

5:30 PM

Julie Bennett

Poster Session 1

"iSOoTH: A study on children's sore throats to inform the development of a Group A Streptococcal vaccine (#166)

5:30 PM

Julie Bennett

Poster Session 1

TREAT-SC a randomised, double-blinded, placebo-controlled trial of early short course oral dexamethasone for the treatment of sydenham’s chorea in children (117514)

3:45 PM

Kathryn Roberts

Plenary 4 - Rapid Fire Session

Immune Responses In Siblings With Acute Rheumatic Fever – A Case Study (#219)

5:30 PM

Natalie Lorenz

Poster Session 2

Invasive Group A Streptococcus (iGAS) surveillance gets the green light: a clear-cut microbiological specimen sterility framework for comprehensive and consistent laboratory surveillance. (#118)

5:30 PM

Andrew Fox-Lewis

Poster Session 1

Autoantigen biomarker discovery for acute rheumatic fever: Application of protein fragment bead arrays to cohort studies in Aotearoa New Zealand and Australia (118403)

10:06 AM

Lauren Carlton

Plenary 7 - Autoimmunity and Its Long Tail

Building laboratory capacity to advance Strep A vaccine development in Aotearoa New Zealand (#189)

5:30 PM

Aimee Paterson

Poster Session 1

Identification of RNA Biomarkers for Acute Rheumatic Fever (ARF) (#259)

5:30 PM

Lara Oberski

Poster Session 2

The Emergence and Impact of M1_UK on Invasive Group A Streptococcus Disease in Aotearoa New Zealand (#154)

5:30 PM

Anna Vesty

Poster Session 1

Rapua te mea nagro ka tau- a qualitative, Indigenous-informed approach to vaccine development. (118028)

2:42 PM

Anneka Anderson

Plenary 3 - Big Picture Vaccine Development

Addressing Evidence Gaps in ARF Treatment - from the Aotearoa hydroxychloroquine pilot to an international adaptive platform trial  (118488)

11:51 AM

Rachel Webb

Plenary 11 - Lancefield Time Machine - The Shape of Things to Come

Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development (#277)

5:30 PM

Shannon Leilua

Poster Session 2

A peptide epitope biomarker signature that differentiates acute rheumatic fever from related clinical presentations (118534)

12:03 PM

Tim Barnett

Plenary 11 - Lancefield Time Machine - The Shape of Things to Come

Severe GAS infections in pregnancy and the peripartum period in South Auckland, New Zealand, 2023.  (#157)

5:30 PM

Rachel Webb

Poster Session 1

Severe paediatric invasive group A streptococcal infections at Starship Children’s Hospital, Auckland, Jan 2023 - Jan 2025 (#158)

5:30 PM

Rachel Webb

Poster Session 1